It seems that exploring the exact relationship between sleep disorders, metabolic syndrome, and Aβ, tau or alpha-synuclein pathology will help to discover new pathogenic mechanisms and therapeutic targets in dementia. The gene discussed is MAPT; the disease is metabolic syndrome.